Arenicin-1 vs omega-conotoxin MVIIA
Head-to-head comparison of Arenicin-1 (Arenicin-1) and omega-conotoxin MVIIA (Ziconotide) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Arenicin-1 | omega-conotoxin MVIIA |
|---|---|---|
| Category | Marine-Derived | Marine-Derived |
| Full Name | Arenicin-1 | Ziconotide |
| Molecular Weight | 2079 Da | 2639 Da |
| Half-Life | n/a | 4.5 h (CSF) |
| Amino Acids | 21 | 25 |
| Typical Dose | n/a | 1.2 mcg/day initial, titrate as tolerated |
| Route | preclinical | intrathecal |
| Purity | ≥98% | ≥98% |
| Studies Count | 76 | 78 |
| Research Status | Pre-clinical | Approved |
Arenicin-1 Benefits
- ✓antimicrobial
- ✓anti-biofilm
- ✓membrane-active
omega-conotoxin MVIIA Benefits
- ✓analgesic
- ✓ion-channel blocker
- ✓neuroactive
Arenicin-1 Dosing
bacterial infection|biofilm disruption
omega-conotoxin MVIIA Dosing
chronic refractory pain|CaV2.2
Arenicin-1 Side Effects
- ⚠Arenicola marina
omega-conotoxin MVIIA Side Effects
- ⚠Conus magus
Research Overview
Arenicin-1
Marine annelid peptide with strong preclinical antibacterial activity and a stable structural motif that is useful for peptide engineering.
omega-conotoxin MVIIA
Foundational marine peptide drug; approved as ziconotide for intrathecal treatment of severe chronic pain when other therapies fail.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.
Related Comparisons
Common Stacking Partners
Arenicin-1 stacks with:
Arenicola marinabeta-hairpinantibiotic
omega-conotoxin MVIIA stacks with:
Conus magusomega-conotoxinpain
marine-derivedbioactiveantimicrobial peptidebiofilmcone snailpeptide drug